Alfred Arnold

2,8‐Diazido‐ATP — a short‐length bifunctional photoaffinity label for photoaffinity cross‐linking of a stable F₁ in ATP synthase (from thermophilic bacteria PS3)

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: Results of the rt-PA-APSAC patency study (TAPS)

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression

Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety

Randomized Comparison of Primary Coronary Angioplasty With Thrombolytic Therapy in Low Risk Patients With Acute Myocardial Infarction

Severe Hypoglycemia and Risks of Vascular Events and Death

The Risk of Stroke in Patients with Acute Myocardial Infarction after Thrombolytic and Antithrombotic Treatment

Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes

Treatment of Pulmonary Arterial Hypertension

Aspirin, Heparin, and Fibrinolytic Therapy in Suspected Acute Myocardial Infarction

Relationship Between Spontaneous and Iatrogenic Hypoglycemia and Mortality in Patients Hospitalized With Acute Myocardial Infarction

Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour

Incidence of sudden cardiac death after ventricular fibrillation complicating acute myocardial infarction: a 5-year cause-of-death analysis of the FAST-MI 2005 registry

Irregular coronary lesion morphology after thrombolysis predicts early clinical instability

Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials

Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

A Comparison of Immediate Coronary Angioplasty with Intravenous Streptokinase in Acute Myocardial Infarction

Angiographic assessment of the infarct-related residual coronary stenosis after spontaneous or therapeutic thrombolysis

Antioxidants and Atherosclerotic Heart Disease

The importance of selenium to human health

Fibrinogen, t-PA, and PAI-1 plasma levels in patients with pulmonary hypertension.

Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack

A randomized trial of intravenous heparin in conjunction with anistreplase (anisoylated plasminogen streptokinase activator complex) in acute myocardial infarction: The Duke University clinical cardiology study (DUCCS) 1

The effect of completeness of revascularization on event-free survival at one year in the arts trial

Hemodynamic Shear Stress and Its Role in Atherosclerosis

The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes

Heparin and Low-Molecular-Weight Heparin

Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor

Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy

Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease

Idarucizumab for Dabigatran Reversal

Early versus Late Parenteral Nutrition in Critically Ill Adults

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes

Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock

Inflammation, Atherosclerosis, and Coronary Artery Disease

Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men

Percutaneous Transluminal Coronary Angioplasty

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

The pathogenesis of atherosclerosis: a perspective for the 1990s

Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA)

Patch Clamp Studies on V-type ATPase of Vacuolar Membrane of Haploid Saccharomyces cerevisiae

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

Intensive Insulin Therapy in the Medical ICU

Risk stratification for sudden cardiac death: current status and challenges for the future

Management of Diabetes and Hyperglycemia in Hospitals

Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

HIF-1α is required for development of the sympathetic nervous system

Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells.

[57] Proton-conducting portion (F0) from Escherichia coli ATP synthase: Preparation, dissociation into subunits, and reconstitution of an active complex

A prospective, randomized trial comparing combination half-dose tissue-type plasminogen activator and streptokinase with full-dose tissue-type plasminogen activator. Kentucky Acute Myocardial Infarction Trial (KAMIT) Group.

Autophagy in yeast demonstrated with proteinase-deficient mutants and conditions for its induction.

Toward a New Frontier in Myocardial Reperfusion Therapy

ACC/AHA guidelines for coronary angiography11“ACC/AHA Guidelines for Coronary Angiography” was approved by the American College of Cardiology Board of Trustees in October 1998 and by the American Heart Association Science Advisory and Coordinating Committee in December 1998.22When citing this document, the American College of Cardiology and the American Heart Association request that the following format be used: Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SD, Pepine CJ, Watson RM. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol1999;33:1756–82433This document is available on the websites of the ACC (www.acc.org) and the AHA (www.americanheart.org). Reprints of this document (the complete guidelines) are available for $5 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint No. 71-0164. To obtain a reprint of the shorter version (executive summary and summary of recommendations) published in the May 4, 1999, issue of Circulation, ask for reprint No. 71-0163. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org

Insulin Therapy for Critically Ill Hospitalized Patients

Photoaffinity labeling of the coupling factor 1 from the thermophilic bacterum PS3 by 8‐azido ATP

Glucometrics in Patients Hospitalized With Acute Myocardial Infarction

Appropriate use of heparin. Empiric vs nomogram-based dosing.

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.

Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization

THE ATP SYNTHASE—A SPLENDID MOLECULAR MACHINE

Use of a Standardized Heparin Nomogram to Achieve Therapeutic Anticoagulation After Thrombolytic Therapy in Myocardial Infarction

Epidemiology and Genetics of Sudden Cardiac Death

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

High-affinity potassium uptake system in Bacillus acidocaldarius showing immunological cross-reactivity with the Kdp system from Escherichia coli

8-Azido-adenosine 5'-triphosphate as a Photoaffinity Label for Bacterial F1 ATPase

Measurement of cytosolic, mitochondrial, and Golgi pH in single living cells with green fluorescent proteins

Risks and Benefits of Nutritional Support During Critical Illness

Does PTCA in Acute Myocardial Infarction Affect Mortality and Reinfarction Rates?

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

[52] K+-ATPase from Escherichia coli: Isolation and characterization

Predictors of Outcome in Patients With Acute Coronary Syndromes Without Persistent ST-Segment Elevation

Catalytic properties of chloroplast F1-ATPase modified at catalytic or noncatalytic sites by 2-azido adenine nucleotides.

An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction

Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock

The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke

Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture.

Assessment of total catalytic sites and the nature of bound nucleotide participation in photophosphorylation.

The sites of labeling of the beta-subunit of bovine mitochondrial F1-ATPase with 8-azido-ATP.

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

The F₀ Complex of the Escherichia Coli ATP Synthase

Weekend versus Weekday Admission and Mortality from Myocardial Infarction

Eine einfache Darstellung von 8‐Azidoadenosin‐5′‐triphosphat; ein Agens zur Photoaffinitätsmarkierung von ATP‐bindenden Proteinen

The ubiquitin conjugation system is required for ligand-induced endocytosis and degradation of the growth hormone receptor.

2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Coronary patency after intravenous infusion of recombinant tissue-type plasminogen activator in acute myocardial infarction

Impaired glucose metabolism predicts mortality after a myocardial infarction

Prediction of mortality following hospital discharge after thrombolysis for acute myocardial infarction: is there a need for coronary angiography?

Increased serum levels of fibrinogen degradation products due to treatment with recombinant tissue-type plasminogen activator for acute myocardial infarction are related to bleeding complications, but not to coronary patency

Estimated gain in life expectancy: A simple tool to select optimal reperfusion treatment in individual patients with evolving myocardial infarction

Thrombolytic therapy for evolving myocardial infarction needs an approach that integrates benefit and risk

Effect of continued rt-PA administration on the residual stenosis after initially successful recanalization in acute myocardial infarction – a quantitative coronary angiography study of a randomized trial

Significance of initial ST segment elevation and depression for the management of thrombolytic therapy in acute myocardial infarction. European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator.

Recombinant tissue-type plasminogen activator and immediate angioplasty in acute myocardial infarction. One-year follow-up. The European Cooperative Study Group.

Familial Sudden Death Is an Important Risk Factor for Primary Ventricular Fibrillation

Tailored thrombolytic therapy. A perspective.

Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial.

Benefits and risks of thrombolysis for acute myocardial infarction

Plasma fibrinopeptide A levels in patients with acute myocardial infarction treated with alteplase. Correlation with concomitant heparin, coronary artery patency, and recurrent ischemia. The European Cooperative Study Group.

Coronary angioplasty of the unstable angina related vessel in patients with multivessel disease

An automated continuous assay of membrane-bound and soluble ATPases and related enzymes